Future Health ETF (BMED)
NYSEARCA: BMED · IEX Real-Time Price · USD
24.70
-0.23 (-0.94%)
Jul 2, 2024, 12:26 PM EDT - Market closed
| Assets | $4.01M |
| Expense Ratio | 0.85% |
| PE Ratio | 36.87 |
| Shares Out | 160,000 |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.03% |
| Ex-Dividend Date | Dec 20, 2023 |
| Payout Ratio | 1.09% |
| 1-Year Return | +0.59% |
| Volume | 404 |
| Open | 24.70 |
| Previous Close | 24.93 |
| Day's Range | 24.70 - 24.70 |
| 52-Week Low | 20.59 |
| 52-Week High | 26.45 |
| Beta | 0.82 |
| Holdings | 142 |
| Inception Date | Sep 29, 2020 |
About BMED
Fund Home PageThe Future Health ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.
Top 10 Holdings
26.53% of assets| Name | Symbol | Weight |
|---|---|---|
| Boston Scientific Corporation | BSX | 3.75% |
| Cencora | COR | 3.44% |
| BlackRock Cash Funds Treasury SL Agency | XTSLA | 3.22% |
| Intuitive Surgical, Inc. | ISRG | 2.77% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.59% |
| West Pharmaceutical Services, Inc. | WST | 2.59% |
| Amgen Inc. | AMGN | 2.30% |
| The Cooper Companies, Inc. | COO | 2.13% |
| BioMarin Pharmaceutical Inc. | BMRN | 1.89% |
| Danaher Corporation | DHR | 1.85% |
News
BlackRock strategist explains ‘2 compelling reasons to own health care' stocks in 2023
BlackRock U.S. Head of Thematic and Active Equity ETFs Jay Jacobs joins Yahoo Finance Live to discuss fiscal spending in 2023, clean energy, ETFs, health care stocks, investor sentiment, layoffs acros...
1 year ago - Yahoo Finance
